RANCHO CORDOVA, Calif.,
Jan. 21, 2019 /PRNewswire/ -- ThermoGenesis Corp,
a private corporation owned by Cesca Therapeutics (Nasdaq:
KOOL), and a market leader in automated cellular processing
and autologous cell therapies for regenerative medicine, today
announced the construction and qualification of a new Class
100,000, GMP compliant assembly facility to manufacture all
X-Series cell processing disposables.
Haihong Zhu, President of
ThermoGenesis, stated, "Now that we have completed the transfer of
assembly of both our cell processing disposables and automated
Control Module and Docking Station devices from third-party
vendors to our in-house facility in Rancho Cordova, we have better control over
our supply chain and are able to provide even higher quality
products and improved customer service. Equally important,
ThermoGenesis is now better equipped to scale its manufacturing
rate to keep pace with the rising demand for the X-Series 'closed
system' automated cell processing products." These products
include:
- The X-LAB® System, for harvesting
purified mononuclear cells from blood or bone marrow
- The X-WASH® System, for washing
contaminants from cell suspensions
- The PXP® System, for "Point of Care"
harvesting of purified mononuclear cells and platelets from blood
or bone marrow
About ThermoGenesis
Corp.
ThermoGenesis
develops, commercializes and markets a full suite of solutions for
automated clinical biobanking, point-of-care applications, and
automation for immuno-oncology. The Company has developed an
automated, functionally-closed CAR-TXpress™ platform
to streamline the manufacturing process for the emerging CAR-T
immunotherapy market. For additional information, please visit:
www.thermogenesis.com.
About Cesca Therapeutics Inc.
Cesca Therapeutics
Inc. is a market leader in cell processing technologies and
autologous cell therapies for regenerative medicine. For more
information, visit: www.cescatherapeutics.com.
Company Contact:
ThermoGenesis Corp
Wendy Samford
916-858-5191
ir@thermogenesis.com
Investor Contact:
Rx Communications
Paula Schwartz
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/thermogenesis-corp-completes-construction-and-qualification-of-in-house-clean-room-for-assembly-of-all-x-series-cell-processing-disposables-300781190.html
SOURCE Cesca Therapeutics Inc.